NexgenRX (TSX-V: NXG) announced an exclusive supply agreement with CannTrust Inc. (TSX: TRST) this morning. Under the terms of the agreement CannTrust will provide Nexgen Rx patients for an initial 5 year term, that will be renewable if the deal is successful.
NexgenRx’s plans to offer its patients medicinal cannabis from CannTrust’s wide range of products while in conjunction having a portion of that patients percription calculated and applied by their health care plan before purchase. While
checking out patients will be able to pay for their
intended portion of their medicine. This is the first
system that works with individuals health care to
create a seamless process in the check out line.
CannTrust will be offering patients pharmaceutical grade cannabis & cannabis based products in convenient and safe dosages. The company is known for becoming one of the industry leaders in high quality,
standardized medicinal cannabis products.
Ron Loucks, President & CEO of NexgenRx gave this statement in the press release:
“CannTrust® is focused on providing high quality products and service to our patients. Having a real time adjudication process will make it easier and more convenient for NexgenRx plan members to purchase medical cannabis, while maintaining the integrity of health care plans”, said Brad Rogers, President of CannTrust®.”
You may be interested
Uttarakhand Becomes the First State in India to Issue Industrial Hemp Cultivation LicenseEditor - July 13, 2018
Uttarakhand has become the first state in India to have issued a legal license for the commercial cultivation of industrial hemp. The Indian Industrial Hemp Association (IIHA)…
British Colombia Announces List of Licensed Distributors Ahead of Recreational CannabisEditor - July 13, 2018
The British Colombia Liquor Distribution Branch has announced a list of the 31 federally licensed cannabis manufacturers and distributors ahead of October 2018, when the Cannabis Act…
New York Department of Health to Allow Medical Cannabis as an Opioid ReplacementEditor - July 13, 2018
Earlier this month, the New York State Department of Health announced new emergency regulations to allow patients prescribed opioids to be given a license to obtain medicinal…